MapLight Therapeutics Inc.
MPLT | NASDAQ
$10.90
-$0.02 (-0.18%)
At close: Sep 21, 2026, 4:00 PM ET
$11.20
+$0.30 (+2.75%)
After-hours:
Sep 21, 2026, 6:22 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Net Income | -161.15M | -77.58M | -55.71M | -30.02M |
Depreciation & Amortization | 578K | 701K | 556K | 574K |
Stock-Based Compensation | n/a | n/a | n/a | n/a |
Other Working Capital | -12.84M | -3.07M | 2.04M | 1.72M |
Other Non-Cash Items | 35.27M | 1.13M | 1.11M | 1.14M |
Deferred Income Tax | n/a | n/a | n/a | n/a |
Change in Working Capital | -12.84M | -3.07M | 2.04M | 1.72M |
Operating Cash Flow | -138.14M | -78.82M | -52.01M | -26.58M |
Capital Expenditures | -473K | -770K | -462K | -746K |
Cash Acquisitions | n/a | n/a | n/a | n/a |
Purchase of Investments | -408.23M | -125.02M | n/a | n/a |
Sales Maturities Of Investments | 85.5M | 45M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a |
Investing Cash Flow | -323.21M | -80.79M | -462K | -746K |
Debt Repayment | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -5.02M | -2.19M | n/a | n/a |
Financial Cash Flow | 469.82M | 118.06M | 104.57M | 33.17M |
Net Cash Flow | 8.48M | -41.52M | 52.1M | 27.67M |
Free Cash Flow | -138.61M | -79.59M | -52.47M | -27.32M |
Adj. Free Cash Flow | -138.61M | -79.59M | -52.47M | -27.32M |
Maintenance CapEx | -473K | -701K | -462K | -574K |
Growth CapEx | n/a | -69K | n/a | -172K |
Owner Earnings | -138.61M | -79.52M | -52.47M | -27.15M |
Add to Watchlist
Select watchlists to add or remove MPLT